CTI BioPharma to Present at the BioCentury NewsMakers in the Biotech Industry Conference

21:51 EDT 30 Aug 2017 | PR Newswire

SEATTLE, Aug. 31, 2017 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that management will present at the 24th Annual BioCentury NewsMakers in the Biotech Industry Conference Friday, September 8, 2017, at 11:00 a.m. ET in New York, NY.

The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at

About CTI BioPharma

CTI BioPharma Corp. is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. CTI BioPharma has a late-stage development pipeline, including pacritinib for the treatment of patients with myelofibrosis. CTI BioPharma is headquartered in Seattle, Washington. For additional information and to sign up for email alerts and get RSS feeds, please visit

CTI BioPharma Contacts:

Ed Bell
+1 206-272-4345

View original content with multimedia:

SOURCE CTI BioPharma Corp.


More From BioPortfolio on "CTI BioPharma to Present at the BioCentury NewsMakers in the Biotech Industry Conference"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...